Heidi S Harvie MD , MBA, MSCE
Urogynecology & Pelvic Reconstructive Surgery
Associate Professor, Obstetrics & Gynecology, Perelman School of Medicine, Director of Urogynecology at Pennsylvania Hospital
Join to View Full Profile
3400 Spruce Street1000 Courtyard BuildingPhiladelphia, PA 19104
Phone+1 215-829-2345
Dr. Harvie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Urogynecology and Reconstructive Pelvic Surgery (Obgyn), 2006 - 2009- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 2002 - 2006
Perelman School of Medicine at the University of PennsylvaniaClass of 2002
Certifications & Licensure
PA State Medical License 2002 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Female Pelvic Medicine and Reconstructive Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Study of Uterine Prolapse Procedures - Randomized Trial Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- Validity and responsiveness of EuroQol 5 dimension 5 level in the abortion care setting.Emma Gilmore, Arden Mcallister, Louise B Russell, Melissa Montoya, Nathanael C Koelper
American Journal of Obstetrics and Gynecology. 2026-04-01 - Design of Transurethral Bulking Agent Injection Versus Single-Incision Sling Trial.Emily S Lukacz, Shawn A Menefee, Benjamin Carper, Sara Collins, Kimberly McMillian
Urogynecology. 2026-02-01 - Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply.Heidi S Harvie, Christopher Chermansky, Holly E Richter
JAMA. 2025-10-28
Journal Articles
- Success and Failure Are Dynamic, Recurrent Event States After Surgical Treatment for Pelvic Organ ProlapseEmily Lukacz, Halina Zyczynski, Heidi S Harvie, Gena Dunivan, Vivian Sung, American Journal of Obstetrics and Gynecology
- Responsiveness and Minimally Important Difference of SF-6D and EQ-5D Utility Scores for the Treatment of Pelvic Organ ProlapseHeidi Harvie, MD, American Journal of Obstetrics and Gynecology
Authored Content
- Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized TrialFebruary 2018
Press Mentions
Sling and Botox Comparable for Female Mixed Urinary IncontinenceMay 7th, 2025- Is Injection or Surgery Better for Mixed Urinary Incontinence?May 5th, 2025
Grant Support
- Pelvic Floor Disorders NetworkUNIVERSITY OF PENNSYLVANIA2011–2027
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
